scorecardresearch
Add as a preferred source on Google
Wednesday, November 12, 2025
TopicCOVID-19

Topic: COVID-19

Drug patented in 1960s can halve recovery time in mild & moderate Covid cases, study finds

Citing the findings of a clinical trial involving 200 patients, a team of researchers has urged the Health Ministry to include antiviral drug Indomethacin in the country's Covid treatment protocols.

Delhi govt’s new SOP for schools – check all entry gates, ensure quarantine room

The Delhi Directorate of Education Schools asked schools to guide students to not share their lunch and stationery with others.

India’s Covid R value crosses 1 for the first time since January, Delhi & UP register 2.12

India’s overall rise in R, an indicator of how fast infection is spreading, from 0.77 in March to 1.07 this month is primarily driven by a spike in cases in Delhi, UP and Haryana.

First, Beijing failed to prevent Covid in Shanghai. Now, it’s struggling to censor criticism

The Shanghai lockdown isn’t just about the Covid-19 pandemic but also about the elite politics between the Shanghai and Beijing regions.

What is mucosal immunity & how nasal sprays and vaccines will help fight Covid-19

Nasal vaccines and sprays have been subject of discussion since early days of Covid, with research finally making headway into actually testing them for mucosal immunity.

Study on mice shows Covid virus leads to brain neuron death, higher anxiety, reduced cognition

Researchers injected protein into mice brains & observed behaviour through tests. Protein didn't directly cause cell death, but induced toxicity into supporting cells around neuron.

India’s daily Covid cases fall below 1,000 for first time since April 2020

Active Covid cases are below 13,000, the lowest in 714 days, and the daily positivity rate was recorded at 0.29% according to the Health Ministry.

From previous shortages, world moves to possible excess of Covid-19 vaccines

The global vaccine industry is facing waning demand as many late-to-market producers fight over a slowing market.

Back to normal, but a new one — what is govt’s road map for end of Covid curbs

Although Disaster Management Act will no longer be invoked after 31 March, states have been advised to continue Covid surveillance and pursue evidence-based decisionmaking.

US, EU draft to amend India’s TRIPS waiver proposal shows West hypocrisy at its best

The TRIPS Agreement focused on the IPRs that restricted access and Covid vaccine supplies. India must shout a defiant ‘no’ against a sloppy US draft.

On Camera

BBC scandal: Britain’s elite establishment is rapidly sinking

The impact of all this upheaval is unmooring. We search for the BBC to confirm that Britain still exists and find it missing.

India’s factory data may get reality check in MoSPI’s new IIP plan, defunct factories to be dropped

MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.